Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients

Genomic rearrangement in anaplastic lymphoma kinase (ALK) gene occurs in 3−7% of patients with non-small-cell lung cancer (NSCLC). The detection of this alteration is crucial as ALK positive NSCLC patients benefit from ALK inhibitors, which improve both the patient's quality of life and overall...

Full description

Saved in:
Bibliographic Details
Main Authors: Sánchez-Herrero Estela, Provencio Mariano, Romero Atocha
Format: article
Language:EN
ES
Published: De Gruyter 2020
Subjects:
Online Access:https://doaj.org/article/5adcc9d796aa44beae1ace9bc24a82b4
Tags: Add Tag
No Tags, Be the first to tag this record!